“Safe” gene editing

The New England Journal of Medicine carries a brief article about “Controlling CRISPR-Cas9 Gene Editing” (subscription required).  The upshot: RNA used as a medicine, as in the case of “CRISPR” to edit genes, can hang around well after administration, and alter genes other than the ones intended to be altered.  These “off-target” effects could lead … Continue reading "“Safe” gene editing"

Source: blog.bioethics.net - July 19, 2019 Category: Medical Ethics Authors: Jon Holmlund Tags: Genetics Health Care bioethics biotechnology syndicated Source Type: blogs